CITI/PUT/BAYER/22/0.1/19.12.24 Stock

DE000KJ2JEG2

Real-time Boerse Frankfurt Warrants 13:37:01 2024-05-31 EDT
0.019 ^EUR	+5.56%

1 month	-62.00%
3 months	-36.67%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BAYER AG

Latest news about BAYER AG

German Shares Edge Up as Eurozone Sentiment Data Improves	05-30	MT
Burning Rock Biotech to Work With Bayer to Increase Patient Access to Precision Cancer Medicines in China	05-30	MT
Bayer Wins US FDA's Regenerative Medicine Advanced Therapy Tag for Parkinson's Disease Drug	05-30	MT
Bayer: 'RMAT' designation obtained in the USA for Parkinson's disease	05-30	CF

More news

Quotes 5-day view

Date	Price	Change
24-05-31	0.019	+5.56%
24-05-30	0.018	-28.00%
24-05-29	0.025	+38.89%
24-05-28	0.018	+5.88%
24-05-27	0.017	-29.17%

Real-time Boerse Frankfurt Warrants

Last update May 31, 2024 at 01:37 pm

More quotes

Static data

Product type	Warrant Plain-Vanilla
Buy / Sell	PUT
Underlying	BAYER AG
Issuer	Citi
WKN	KJ2JEG
ISIN	DE000KJ2JEG2
Date issued	2023-12-07
Strike	22 €
Maturity	2024-12-19 (200 Days)
Parity	10 : 1
Emission price	0.12 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.14 €
Lowest since issue	0.01 €

Company Profile

Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.5%). Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).

Sector

More about the company